Background: Radiation therapy (RT) remains a critical component of multimodality treatment for medulloblastoma. Traditionally, clinicians strive to start RT within 4-5 weeks of surgery, but the optimal timing after surgery remains unclear. Methods: Using the National Cancer Database, we identified pediatric and adolescent patients with medulloblastoma treated with curative-intent surgery, RT, and chemotherapy. Factors associated with early or delayed RT were identified using Pearson chi-squared tests. Overall survival (OS) differences based on RT timing were compared using the Kaplan-Meier estimator with log-rank tests. Patient, tumor, and treatment characteristics associated with OS were analyzed with univariate and multivariate Cox proportional hazards models. Results: Among the 1338 patients analyzed, early RT (defined as initiation ≤3 wk after surgery) was associated with younger age, M1-3 disease, and subtotal resection. Patients who initiated RT early had decreased 5-year OS compared with patients who initiated RT 3.1-4, 4.1-5, or >5 weeks after surgery (72.5% vs. 80.5%, 79.4%, and 77.8%, respectively; P = 0.019), but there was no significant difference in OS among the latter 3 groups (P = 0.788). On multivariate analysis, early RT versus the 3.1- to 4-week interval was significantly associated with poorer OS (adjusted hazard ratio, 1.72; 95% CI: 1.19-2.48; P = 0.004), while time to RT of >5 weeks but within 90 days of surgery did not adversely impact OS (P = 0.563). Conclusions: In this large national database analysis, delaying RT within 90 days of surgery was not associated with inferior outcomes. Although clinical judgment remains paramount, postoperative RT timing should allow for healing and the development of an optimal treatment plan.
Background: Radiation therapy (RT) remains a critical component of multimodality treatment for medulloblastoma. Traditionally, clinicians strive to start RT within 4-5 weeks of surgery, but the optimal timing after surgery remains unclear. Methods: Using the National Cancer Database, we identified pediatric and adolescent patients with medulloblastoma treated with curative-intent surgery, RT, and chemotherapy. Factors associated with early or delayed RT were identified using Pearson chi-squared tests. Overall survival (OS) differences based on RT timing were compared using the Kaplan-Meier estimator with log-rank tests. Patient, tumor, and treatment characteristics associated with OS were analyzed with univariate and multivariate Cox proportional hazards models. Results: Among the 1338 patients analyzed, early RT (defined as initiation ≤3 wk after surgery) was associated with younger age, M1-3 disease, and subtotal resection. Patients who initiated RT early had decreased 5-year OS compared with patients who initiated RT 3.1-4, 4.1-5, or >5 weeks after surgery (72.5% vs. 80.5%, 79.4%, and 77.8%, respectively; P = 0.019), but there was no significant difference in OS among the latter 3 groups (P = 0.788). On multivariate analysis, early RT versus the 3.1- to 4-week interval was significantly associated with poorer OS (adjusted hazard ratio, 1.72; 95% CI: 1.19-2.48; P = 0.004), while time to RT of >5 weeks but within 90 days of surgery did not adversely impact OS (P = 0.563). Conclusions: In this large national database analysis, delaying RT within 90 days of surgery was not associated with inferior outcomes. Although clinical judgment remains paramount, postoperative RT timing should allow for healing and the development of an optimal treatment plan.
Authors: Jillian R Gunther; Mariko Sato; Murali Chintagumpala; Leena Ketonen; Jeremy Y Jones; Pamela K Allen; Arnold C Paulino; M Fatih Okcu; Jack M Su; Jeffrey Weinberg; Nicholas S Boehling; Soumen Khatua; Adekunle Adesina; Robert Dauser; William E Whitehead; Anita Mahajan Journal: Int J Radiat Oncol Biol Phys Date: 2015-05-16 Impact factor: 7.038
Authors: P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544
Authors: Kaitlin M Christopherson; Julie A Bradley; Ronny L Rotondo; David W Pincus; John A Fort; Christopher G Morris; Nancy P Mendenhall; Robert B Marcus; Daniel J Indelicato Journal: Acta Oncol Date: 2014-07-03 Impact factor: 4.089
Authors: Yu-Wei Chen; Brandon A Mahal; Vinayak Muralidhar; Michelle Nezolosky; Clair J Beard; Robert B Den; Felix Y Feng; Karen E Hoffman; Neil E Martin; Peter F Orio; Paul L Nguyen Journal: Int J Radiat Oncol Biol Phys Date: 2015-12-14 Impact factor: 7.038
Authors: J O del Charco; T W Bolek; W M McCollough; B L Maria; A Kedar; R C Braylan; J P Mickle; J M Buatti; N P Mendenhall; R B Marcus Journal: Int J Radiat Oncol Biol Phys Date: 1998-08-01 Impact factor: 7.038
Authors: Jeffrey C Thompson; Stephanie S Yee; Andrea B Troxel; Samantha L Savitch; Ryan Fan; David Balli; David B Lieberman; Jennifer D Morrissette; Tracey L Evans; Joshua Bauml; Charu Aggarwal; John A Kosteva; Evan Alley; Christine Ciunci; Roger B Cohen; Stephen Bagley; Susan Stonehouse-Lee; Victoria E Sherry; Elizabeth Gilbert; Corey Langer; Anil Vachani; Erica L Carpenter Journal: Clin Cancer Res Date: 2016-09-06 Impact factor: 12.531
Authors: Sunny Shah; Kevin Gates; Chase Mallory; Muni Rubens; Ossama M Maher; Toba N Niazi; Ziad Khatib; Rupesh Kotecha; Minesh P Mehta; Matthew D Hall Journal: Adv Radiat Oncol Date: 2021-03-26
Authors: Sean M Liu; Eric D Brooks; M Laura Rubin; David R Grosshans; Steven J Frank; Mary Frances McAleer; Susan L McGovern; Arnold C Paulino; Kristina D Woodhouse Journal: Int J Part Ther Date: 2020-12-31
Authors: Stefan Dietzsch; Felix Placzek; Klaus Pietschmann; André O von Bueren; Christiane Matuschek; Albrecht Glück; Matthias Guckenberger; Volker Budach; Jutta Welzel; Christoph Pöttgen; Heinz Schmidberger; Frank Heinzelmann; Frank Paulsen; Montserrat Pazos Escudero; Rudolf Schwarz; Dagmar Hornung; Carmen Martini; Anca Ligia Grosu; Georg Stueben; Karolina Jablonska; Juergen Dunst; Heidi Stranzl-Lawatsch; Karin Dieckmann; Beate Timmermann; Torsten Pietsch; Monika Warmuth-Metz; Brigitte Bison; Robert Kwiecien; Martin Benesch; Nicolas U Gerber; Michael A Grotzer; Stefan M Pfister; Steven C Clifford; Katja von Hoff; Sabine Klagges; Stefan Rutkowski; Rolf-Dieter Kortmann; Martin Mynarek Journal: Adv Radiat Oncol Date: 2020-10-07